NCT04238819 2026-03-02
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Phase 1/2 Completed
Clinical Trials
1 trialsPhase 1/2 × Diffuse Intrinsic Pontine Glioma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all